Core Viewpoint - The company, Haoyuan Pharmaceutical, is actively engaged in the innovative drug sector, providing essential services for clinical trial applications and drug production, with a significant number of projects underway across various global markets [1] Group 1: Business Model and Services - The company's innovative drug-related business model includes quality research and sample preparation services for clinical trial applications [1] - It also offers production services for active pharmaceutical ingredients (APIs) or intermediates in preclinical and clinical stages, as well as commercial production of intermediates for patented drugs [1] Group 2: Project Portfolio and Market Presence - As of the end of 2024, the company has undertaken a total of 892 projects, primarily focused on markets in China, Japan, South Korea, the United States, and Europe [1] - The majority of these projects are in the preclinical and Phase I clinical stages, with some products advancing to Phase II, Phase III, or new drug application stages [1] - The ongoing research projects are expected to enhance the global innovative drug development industry [1]